

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 7.46872684 |
| 2 | ATP synthesis coupled proton transport (GO:0015986) | 7.04174351 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 7.04174351 |
| 4 | respiratory electron transport chain (GO:0022904) | 5.98725697 |
| 5 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.98568329 |
| 6 | electron transport chain (GO:0022900) | 5.84295926 |
| 7 | DNA deamination (GO:0045006) | 5.80175872 |
| 8 | oxidative phosphorylation (GO:0006119) | 5.48250864 |
| 9 | viral transcription (GO:0019083) | 4.73056297 |
| 10 | ribosomal small subunit assembly (GO:0000028) | 4.62555245 |
| 11 | translational termination (GO:0006415) | 4.62252105 |
| 12 | proteasome assembly (GO:0043248) | 4.43568067 |
| 13 | ribosomal small subunit biogenesis (GO:0042274) | 4.40922680 |
| 14 | regulation of mitochondrial translation (GO:0070129) | 4.31738607 |
| 15 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.27530786 |
| 16 | protein maturation by protein folding (GO:0022417) | 4.23421604 |
| 17 | translational elongation (GO:0006414) | 4.23300228 |
| 18 | cotranslational protein targeting to membrane (GO:0006613) | 4.18790301 |
| 19 | protein targeting to ER (GO:0045047) | 4.17723596 |
| 20 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.08312280 |
| 21 | protein localization to endoplasmic reticulum (GO:0070972) | 4.02628131 |
| 22 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.01498529 |
| 23 | ATP biosynthetic process (GO:0006754) | 3.97548442 |
| 24 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.95127360 |
| 25 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.93500461 |
| 26 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.93330118 |
| 27 | ribosomal large subunit biogenesis (GO:0042273) | 3.80066504 |
| 28 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.79345815 |
| 29 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.78127066 |
| 30 | maturation of SSU-rRNA (GO:0030490) | 3.77812366 |
| 31 | translational initiation (GO:0006413) | 3.77521678 |
| 32 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.77478264 |
| 33 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.73438724 |
| 34 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.72699445 |
| 35 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.72699445 |
| 36 | NADH dehydrogenase complex assembly (GO:0010257) | 3.72699445 |
| 37 | translation (GO:0006412) | 3.69559653 |
| 38 | viral life cycle (GO:0019058) | 3.68616522 |
| 39 | chaperone-mediated protein transport (GO:0072321) | 3.66324298 |
| 40 | DNA strand elongation (GO:0022616) | 3.63329358 |
| 41 | protein complex biogenesis (GO:0070271) | 3.62003088 |
| 42 | protein targeting to membrane (GO:0006612) | 3.61803104 |
| 43 | cellular protein complex disassembly (GO:0043624) | 3.59824048 |
| 44 | inner mitochondrial membrane organization (GO:0007007) | 3.57368788 |
| 45 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.57241469 |
| 46 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.57000884 |
| 47 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.56938534 |
| 48 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.55833169 |
| 49 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.53235447 |
| 50 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.51711415 |
| 51 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.51334991 |
| 52 | establishment of protein localization to mitochondrion (GO:0072655) | 3.50572516 |
| 53 | tricarboxylic acid cycle (GO:0006099) | 3.49811195 |
| 54 | protein targeting to mitochondrion (GO:0006626) | 3.49025226 |
| 55 | GDP-mannose metabolic process (GO:0019673) | 3.45605825 |
| 56 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.42068585 |
| 57 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.38967260 |
| 58 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.37621945 |
| 59 | protein localization to mitochondrion (GO:0070585) | 3.35659996 |
| 60 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.33174133 |
| 61 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.32378682 |
| 62 | formation of translation preinitiation complex (GO:0001731) | 3.32053518 |
| 63 | termination of RNA polymerase III transcription (GO:0006386) | 3.31717180 |
| 64 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.31717180 |
| 65 | ribosome biogenesis (GO:0042254) | 3.27910625 |
| 66 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.26987236 |
| 67 | quinone biosynthetic process (GO:1901663) | 3.25802806 |
| 68 | ubiquinone biosynthetic process (GO:0006744) | 3.25802806 |
| 69 | mitochondrial transport (GO:0006839) | 3.25372068 |
| 70 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.23465282 |
| 71 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.22939182 |
| 72 | folic acid metabolic process (GO:0046655) | 3.22137210 |
| 73 | hydrogen ion transmembrane transport (GO:1902600) | 3.21851745 |
| 74 | positive regulation of ligase activity (GO:0051351) | 3.21793087 |
| 75 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.20866705 |
| 76 | cellular component biogenesis (GO:0044085) | 3.19044761 |
| 77 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.16680385 |
| 78 | negative regulation of ligase activity (GO:0051352) | 3.16680385 |
| 79 | purine nucleobase biosynthetic process (GO:0009113) | 3.16475435 |
| 80 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.15786706 |
| 81 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.15786706 |
| 82 | GTP biosynthetic process (GO:0006183) | 3.15636619 |
| 83 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.15461982 |
| 84 | metallo-sulfur cluster assembly (GO:0031163) | 3.14576358 |
| 85 | iron-sulfur cluster assembly (GO:0016226) | 3.14576358 |
| 86 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.13617181 |
| 87 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.13583690 |
| 88 | rRNA processing (GO:0006364) | 3.10579538 |
| 89 | respiratory chain complex IV assembly (GO:0008535) | 3.09308883 |
| 90 | regulation of cellular respiration (GO:0043457) | 3.08035818 |
| 91 | NADH metabolic process (GO:0006734) | 3.07839074 |
| 92 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.07119873 |
| 93 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.06944429 |
| 94 | aerobic respiration (GO:0009060) | 3.05653931 |
| 95 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.05127725 |
| 96 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.05127725 |
| 97 | proline biosynthetic process (GO:0006561) | 3.04948036 |
| 98 | base-excision repair, AP site formation (GO:0006285) | 3.04078963 |
| 99 | UTP metabolic process (GO:0046051) | 3.03779121 |
| 100 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.03568429 |
| 101 | pseudouridine synthesis (GO:0001522) | 3.03215107 |
| 102 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.03171899 |
| 103 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.03043138 |
| 104 | protein complex disassembly (GO:0043241) | 3.02964105 |
| 105 | CTP biosynthetic process (GO:0006241) | 3.02279726 |
| 106 | CTP metabolic process (GO:0046036) | 3.02279726 |
| 107 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.00007647 |
| 108 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.99725449 |
| 109 | establishment of integrated proviral latency (GO:0075713) | 2.97745154 |
| 110 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.97485292 |
| 111 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.97485292 |
| 112 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.97176830 |
| 113 | regulation of oxidative phosphorylation (GO:0002082) | 2.96550638 |
| 114 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.95384280 |
| 115 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.95384280 |
| 116 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.95384280 |
| 117 | rRNA metabolic process (GO:0016072) | 2.94412518 |
| 118 | macromolecular complex disassembly (GO:0032984) | 2.94385290 |
| 119 | nucleoside monophosphate biosynthetic process (GO:0009124) | 2.94323591 |
| 120 | nucleobase biosynthetic process (GO:0046112) | 2.94139765 |
| 121 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.93846967 |
| 122 | COPI coating of Golgi vesicle (GO:0048205) | 2.93828624 |
| 123 | protein deneddylation (GO:0000338) | 2.93224430 |
| 124 | L-methionine salvage (GO:0071267) | 2.92916494 |
| 125 | L-methionine biosynthetic process (GO:0071265) | 2.92916494 |
| 126 | amino acid salvage (GO:0043102) | 2.92916494 |
| 127 | cullin deneddylation (GO:0010388) | 2.92796252 |
| 128 | ribonucleoside monophosphate biosynthetic process (GO:0009156) | 2.92534668 |
| 129 | UTP biosynthetic process (GO:0006228) | 2.90796417 |
| 130 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.88238810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.35828227 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.20477650 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.92002456 |
| 4 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.66564298 |
| 5 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.63495815 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.63093094 |
| 7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.30083849 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.24789306 |
| 9 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.14753369 |
| 10 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.08643819 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.06463715 |
| 12 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.76256820 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.73359139 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.66922546 |
| 15 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.61420025 |
| 16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.58007560 |
| 17 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.46288868 |
| 18 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.42759689 |
| 19 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.41149138 |
| 20 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.40609018 |
| 21 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.34424279 |
| 22 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.32848578 |
| 23 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.27243716 |
| 24 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.24898841 |
| 25 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.19183450 |
| 26 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.13790647 |
| 27 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.09382924 |
| 28 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.04413937 |
| 29 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.04327412 |
| 30 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.03930705 |
| 31 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.01751343 |
| 32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.95195805 |
| 33 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.93115997 |
| 34 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.88537799 |
| 35 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.88399010 |
| 36 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.83272541 |
| 37 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82878822 |
| 38 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.77147237 |
| 39 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.76730173 |
| 40 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.76328771 |
| 41 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.72521834 |
| 42 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.71436261 |
| 43 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.69111651 |
| 44 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65498118 |
| 45 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63563194 |
| 46 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.54933867 |
| 47 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.53475895 |
| 48 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.52414230 |
| 49 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.51598166 |
| 50 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.50496740 |
| 51 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.48856880 |
| 52 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.47835552 |
| 53 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.45203024 |
| 54 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.43617806 |
| 55 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.43396030 |
| 56 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.41585521 |
| 57 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.36503854 |
| 58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36344436 |
| 59 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.36157086 |
| 60 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.36112337 |
| 61 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.34813782 |
| 62 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.34479386 |
| 63 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.32610268 |
| 64 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.28553718 |
| 65 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.27222984 |
| 66 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.24210076 |
| 67 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23519497 |
| 68 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.23339759 |
| 69 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.22702835 |
| 70 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.22649367 |
| 71 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.21961814 |
| 72 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.21278937 |
| 73 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.21192533 |
| 74 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.18622595 |
| 75 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.12917711 |
| 76 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.12239598 |
| 77 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.12078378 |
| 78 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.10184815 |
| 79 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.09476204 |
| 80 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.08429181 |
| 81 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.07779464 |
| 82 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07149880 |
| 83 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.06991216 |
| 84 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.06873397 |
| 85 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.06806900 |
| 86 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.06416661 |
| 87 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04129740 |
| 88 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.02158991 |
| 89 | P68_20966046_ChIP-Seq_HELA_Human | 1.01173130 |
| 90 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.00778961 |
| 91 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.98459018 |
| 92 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.98365704 |
| 93 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.97590861 |
| 94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.96796870 |
| 95 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96552503 |
| 96 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96313713 |
| 97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96105558 |
| 98 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.96075673 |
| 99 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.95862647 |
| 100 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.95032405 |
| 101 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.94404548 |
| 102 | MYC_22102868_ChIP-Seq_BL_Human | 0.92895796 |
| 103 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.92289635 |
| 104 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91988883 |
| 105 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.88617402 |
| 106 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.88292326 |
| 107 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.86363024 |
| 108 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.85914467 |
| 109 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.85015813 |
| 110 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.84836424 |
| 111 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84337231 |
| 112 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.84272847 |
| 113 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.81603175 |
| 114 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.80584521 |
| 115 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79161942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 5.10311262 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.95631941 |
| 3 | MP0006036_abnormal_mitochondrial_physio | 3.75869974 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.72134930 |
| 5 | MP0005360_urolithiasis | 3.43623730 |
| 6 | MP0003186_abnormal_redox_activity | 3.28152281 |
| 7 | MP0003195_calcinosis | 2.99242178 |
| 8 | MP0004957_abnormal_blastocyst_morpholog | 2.94632734 |
| 9 | MP0003646_muscle_fatigue | 2.89384947 |
| 10 | MP0006035_abnormal_mitochondrial_morpho | 2.65588039 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.60520063 |
| 12 | MP0005365_abnormal_bile_salt | 2.41280877 |
| 13 | MP0005332_abnormal_amino_acid | 2.40845096 |
| 14 | MP0009379_abnormal_foot_pigmentation | 2.33716254 |
| 15 | MP0008007_abnormal_cellular_replicative | 2.31849677 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.27697422 |
| 17 | MP0002163_abnormal_gland_morphology | 2.20000632 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 2.15486466 |
| 19 | MP0004043_abnormal_pH_regulation | 2.15417924 |
| 20 | MP0009840_abnormal_foam_cell | 2.06275631 |
| 21 | MP0005636_abnormal_mineral_homeostasis | 1.88776269 |
| 22 | MP0005058_abnormal_lysosome_morphology | 1.82071779 |
| 23 | MP0009643_abnormal_urine_homeostasis | 1.81891450 |
| 24 | MP0002877_abnormal_melanocyte_morpholog | 1.80221927 |
| 25 | MP0005330_cardiomyopathy | 1.75778320 |
| 26 | MP0004215_abnormal_myocardial_fiber | 1.71483805 |
| 27 | MP0005266_abnormal_metabolism | 1.70160994 |
| 28 | MP0004233_abnormal_muscle_weight | 1.68397210 |
| 29 | MP0003718_maternal_effect | 1.66339507 |
| 30 | MP0008932_abnormal_embryonic_tissue | 1.61762200 |
| 31 | MP0001764_abnormal_homeostasis | 1.61409930 |
| 32 | MP0005501_abnormal_skin_physiology | 1.59731112 |
| 33 | MP0003315_abnormal_perineum_morphology | 1.58694731 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.57292052 |
| 35 | MP0003221_abnormal_cardiomyocyte_apopto | 1.57227261 |
| 36 | MP0005319_abnormal_enzyme/_coenzyme | 1.53622159 |
| 37 | MP0000750_abnormal_muscle_regeneration | 1.51962221 |
| 38 | MP0005083_abnormal_biliary_tract | 1.51493157 |
| 39 | MP0005670_abnormal_white_adipose | 1.51109282 |
| 40 | MP0003123_paternal_imprinting | 1.48279588 |
| 41 | MP0004084_abnormal_cardiac_muscle | 1.45002451 |
| 42 | MP0000350_abnormal_cell_proliferation | 1.44439609 |
| 43 | MP0004147_increased_porphyrin_level | 1.44210837 |
| 44 | MP0005377_hearing/vestibular/ear_phenot | 1.43859799 |
| 45 | MP0003878_abnormal_ear_physiology | 1.43859799 |
| 46 | MP0001905_abnormal_dopamine_level | 1.42498961 |
| 47 | MP0000678_abnormal_parathyroid_gland | 1.41483905 |
| 48 | MP0001881_abnormal_mammary_gland | 1.40410392 |
| 49 | MP0004019_abnormal_vitamin_homeostasis | 1.39345740 |
| 50 | MP0001756_abnormal_urination | 1.38660580 |
| 51 | MP0002132_abnormal_respiratory_system | 1.37764241 |
| 52 | MP0000358_abnormal_cell_content/ | 1.36009758 |
| 53 | MP0003077_abnormal_cell_cycle | 1.34898329 |
| 54 | MP0005379_endocrine/exocrine_gland_phen | 1.32505228 |
| 55 | MP0005084_abnormal_gallbladder_morpholo | 1.29660468 |
| 56 | MP0008995_early_reproductive_senescence | 1.28533655 |
| 57 | MP0006276_abnormal_autonomic_nervous | 1.26744544 |
| 58 | MP0000313_abnormal_cell_death | 1.26707694 |
| 59 | MP0010329_abnormal_lipoprotein_level | 1.26144845 |
| 60 | MP0001666_abnormal_nutrient_absorption | 1.25717493 |
| 61 | MP0001529_abnormal_vocalization | 1.24373469 |
| 62 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.21294211 |
| 63 | MP0000749_muscle_degeneration | 1.20914040 |
| 64 | MP0003111_abnormal_nucleus_morphology | 1.17298204 |
| 65 | MP0008789_abnormal_olfactory_epithelium | 1.16833958 |
| 66 | MP0002822_catalepsy | 1.16298920 |
| 67 | MP0002653_abnormal_ependyma_morphology | 1.14104523 |
| 68 | MP0003656_abnormal_erythrocyte_physiolo | 1.12452961 |
| 69 | MP0010094_abnormal_chromosome_stability | 1.11776438 |
| 70 | MP0008058_abnormal_DNA_repair | 1.11106595 |
| 71 | MP0000751_myopathy | 1.10299107 |
| 72 | MP0001727_abnormal_embryo_implantation | 1.10027750 |
| 73 | MP0002210_abnormal_sex_determination | 1.09755647 |
| 74 | MP0002095_abnormal_skin_pigmentation | 1.05669929 |
| 75 | MP0001730_embryonic_growth_arrest | 1.05635410 |
| 76 | MP0005376_homeostasis/metabolism_phenot | 1.05309766 |
| 77 | MP0005451_abnormal_body_composition | 1.04965172 |
| 78 | MP0002269_muscular_atrophy | 1.04914124 |
| 79 | MP0000681_abnormal_thyroid_gland | 1.03357285 |
| 80 | MP0004036_abnormal_muscle_relaxation | 1.03011747 |
| 81 | MP0002118_abnormal_lipid_homeostasis | 1.02553473 |
| 82 | MP0002332_abnormal_exercise_endurance | 1.01612135 |
| 83 | MP0000609_abnormal_liver_physiology | 1.00835824 |
| 84 | MP0004130_abnormal_muscle_cell | 1.00605934 |
| 85 | MP0001346_abnormal_lacrimal_gland | 0.99251597 |
| 86 | MP0004858_abnormal_nervous_system | 0.97421476 |
| 87 | MP0005408_hypopigmentation | 0.97134419 |
| 88 | MP0002019_abnormal_tumor_incidence | 0.96895479 |
| 89 | MP0001661_extended_life_span | 0.95891745 |
| 90 | MP0000013_abnormal_adipose_tissue | 0.95327132 |
| 91 | MP0005666_abnormal_adipose_tissue | 0.92638363 |
| 92 | MP0002796_impaired_skin_barrier | 0.92453470 |
| 93 | MP0003567_abnormal_fetal_cardiomyocyte | 0.91611146 |
| 94 | MP0003786_premature_aging | 0.90766965 |
| 95 | MP0010030_abnormal_orbit_morphology | 0.88750316 |
| 96 | MP0005499_abnormal_olfactory_system | 0.88598101 |
| 97 | MP0005394_taste/olfaction_phenotype | 0.88598101 |
| 98 | MP0005389_reproductive_system_phenotype | 0.86898775 |
| 99 | MP0002638_abnormal_pupillary_reflex | 0.86324284 |
| 100 | MP0000747_muscle_weakness | 0.85804372 |
| 101 | MP0000490_abnormal_crypts_of | 0.84166103 |
| 102 | MP0001853_heart_inflammation | 0.83803397 |
| 103 | MP0010234_abnormal_vibrissa_follicle | 0.83712795 |
| 104 | MP0005385_cardiovascular_system_phenoty | 0.83149759 |
| 105 | MP0001544_abnormal_cardiovascular_syste | 0.83149759 |
| 106 | MP0008775_abnormal_heart_ventricle | 0.81945751 |
| 107 | MP0001697_abnormal_embryo_size | 0.79835660 |
| 108 | MP0005535_abnormal_body_temperature | 0.79663843 |
| 109 | MP0002972_abnormal_cardiac_muscle | 0.77858164 |
| 110 | MP0009697_abnormal_copulation | 0.77348134 |
| 111 | MP0002078_abnormal_glucose_homeostasis | 0.76404191 |
| 112 | MP0002160_abnormal_reproductive_system | 0.75204697 |
| 113 | MP0001929_abnormal_gametogenesis | 0.72543862 |
| 114 | MP0000230_abnormal_systemic_arterial | 0.71820861 |
| 115 | MP0000462_abnormal_digestive_system | 0.71503000 |
| 116 | MP0004133_heterotaxia | 0.71341492 |
| 117 | MP0002971_abnormal_brown_adipose | 0.70608277 |
| 118 | MP0005187_abnormal_penis_morphology | 0.70459815 |
| 119 | MP0000598_abnormal_liver_morphology | 0.69813922 |
| 120 | MP0000015_abnormal_ear_pigmentation | 0.68815277 |
| 121 | MP0001145_abnormal_male_reproductive | 0.68809080 |
| 122 | MP0002234_abnormal_pharynx_morphology | 0.68620539 |
| 123 | MP0002098_abnormal_vibrissa_morphology | 0.68195312 |
| 124 | MP0000759_abnormal_skeletal_muscle | 0.67653108 |
| 125 | MP0000343_altered_response_to | 0.67520206 |
| 126 | MP0001919_abnormal_reproductive_system | 0.66996124 |
| 127 | MP0002080_prenatal_lethality | 0.66551021 |
| 128 | MP0000627_abnormal_mammary_gland | 0.66378667 |
| 129 | MP0009642_abnormal_blood_homeostasis | 0.65875905 |
| 130 | MP0003252_abnormal_bile_duct | 0.65861524 |
| 131 | MP0003137_abnormal_impulse_conducting | 0.65330844 |
| 132 | MP0002138_abnormal_hepatobiliary_system | 0.65081700 |
| 133 | MP0002106_abnormal_muscle_physiology | 0.64464305 |
| 134 | MP0008260_abnormal_autophagy | 0.64182800 |
| 135 | MP0000372_irregular_coat_pigmentation | 0.62870743 |
| 136 | MP0005165_increased_susceptibility_to | 0.61815458 |
| 137 | MP0005220_abnormal_exocrine_pancreas | 0.61016361 |
| 138 | MP0002909_abnormal_adrenal_gland | 0.60175024 |
| 139 | MP0005384_cellular_phenotype | 0.59364525 |
| 140 | MP0000653_abnormal_sex_gland | 0.57839875 |
| 141 | MP0003191_abnormal_cellular_cholesterol | 0.55746316 |
| 142 | MP0010771_integument_phenotype | 0.55723189 |
| 143 | MP0003959_abnormal_lean_body | 0.53895998 |
| 144 | MP0003011_delayed_dark_adaptation | 0.53894876 |
| 145 | MP0001672_abnormal_embryogenesis/_devel | 0.53244885 |
| 146 | MP0005380_embryogenesis_phenotype | 0.53244885 |
| 147 | MP0002161_abnormal_fertility/fecundity | 0.52610538 |
| 148 | MP0004185_abnormal_adipocyte_glucose | 0.52300466 |
| 149 | MP0002970_abnormal_white_adipose | 0.52260804 |
| 150 | MP0005423_abnormal_somatic_nervous | 0.51616161 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 6.13336945 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.91564347 |
| 3 | Acute encephalopathy (HP:0006846) | 5.57386484 |
| 4 | Mitochondrial inheritance (HP:0001427) | 5.23823986 |
| 5 | Hepatic necrosis (HP:0002605) | 5.11231213 |
| 6 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.95975017 |
| 7 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.95975017 |
| 8 | Progressive macrocephaly (HP:0004481) | 4.88771256 |
| 9 | Increased CSF lactate (HP:0002490) | 4.80835693 |
| 10 | Hepatocellular necrosis (HP:0001404) | 4.78729770 |
| 11 | Cerebral edema (HP:0002181) | 4.54804901 |
| 12 | Lactic acidosis (HP:0003128) | 4.12022054 |
| 13 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.08557127 |
| 14 | Lipid accumulation in hepatocytes (HP:0006561) | 4.05246699 |
| 15 | Increased muscle lipid content (HP:0009058) | 3.99361407 |
| 16 | Increased intramyocellular lipid droplets (HP:0012240) | 3.96115462 |
| 17 | Increased hepatocellular lipid droplets (HP:0006565) | 3.92517855 |
| 18 | Abnormal number of erythroid precursors (HP:0012131) | 3.89009342 |
| 19 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.82641036 |
| 20 | Increased serum lactate (HP:0002151) | 3.77060209 |
| 21 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.64695059 |
| 22 | Dicarboxylic aciduria (HP:0003215) | 3.64695059 |
| 23 | Respiratory failure (HP:0002878) | 3.57726718 |
| 24 | Exercise intolerance (HP:0003546) | 3.56142968 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.41409210 |
| 26 | Abnormality of glycolysis (HP:0004366) | 3.40592594 |
| 27 | Increased serum pyruvate (HP:0003542) | 3.40592594 |
| 28 | Lethargy (HP:0001254) | 3.35618359 |
| 29 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.34806459 |
| 30 | Generalized aminoaciduria (HP:0002909) | 3.32124914 |
| 31 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.18937961 |
| 32 | Nausea (HP:0002018) | 3.10265697 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.09426442 |
| 34 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.08670703 |
| 35 | Testicular atrophy (HP:0000029) | 3.02576157 |
| 36 | Hyperglycinuria (HP:0003108) | 2.96616387 |
| 37 | Renal Fanconi syndrome (HP:0001994) | 2.90704084 |
| 38 | 3-Methylglutaconic aciduria (HP:0003535) | 2.88028769 |
| 39 | Glycosuria (HP:0003076) | 2.87085829 |
| 40 | Abnormality of urine glucose concentration (HP:0011016) | 2.87085829 |
| 41 | Palpitations (HP:0001962) | 2.86100037 |
| 42 | Macrocytic anemia (HP:0001972) | 2.85964004 |
| 43 | Abnormality of alanine metabolism (HP:0010916) | 2.85348718 |
| 44 | Hyperalaninemia (HP:0003348) | 2.85348718 |
| 45 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.85348718 |
| 46 | Rhabdomyolysis (HP:0003201) | 2.84925916 |
| 47 | Abnormal gallbladder physiology (HP:0012438) | 2.81868772 |
| 48 | Cholecystitis (HP:0001082) | 2.81868772 |
| 49 | Reticulocytopenia (HP:0001896) | 2.78895751 |
| 50 | Multiple enchondromatosis (HP:0005701) | 2.78097588 |
| 51 | Leukodystrophy (HP:0002415) | 2.73913748 |
| 52 | CNS demyelination (HP:0007305) | 2.73718279 |
| 53 | Methylmalonic aciduria (HP:0012120) | 2.70291145 |
| 54 | Hyperammonemia (HP:0001987) | 2.69898319 |
| 55 | Type I transferrin isoform profile (HP:0003642) | 2.69121560 |
| 56 | Myoglobinuria (HP:0002913) | 2.63451342 |
| 57 | Optic disc pallor (HP:0000543) | 2.62658469 |
| 58 | Degeneration of anterior horn cells (HP:0002398) | 2.62230246 |
| 59 | Abnormality of the anterior horn cell (HP:0006802) | 2.62230246 |
| 60 | Hypokinesia (HP:0002375) | 2.56864463 |
| 61 | Hyperglycinemia (HP:0002154) | 2.55094671 |
| 62 | Exertional dyspnea (HP:0002875) | 2.52860961 |
| 63 | Ragged-red muscle fibers (HP:0003200) | 2.52821693 |
| 64 | Ketoacidosis (HP:0001993) | 2.52104583 |
| 65 | Vomiting (HP:0002013) | 2.51899480 |
| 66 | Hyperthyroidism (HP:0000836) | 2.51863539 |
| 67 | Oral leukoplakia (HP:0002745) | 2.49843413 |
| 68 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.48524295 |
| 69 | Abnormality of glycine metabolism (HP:0010895) | 2.48524295 |
| 70 | Ketosis (HP:0001946) | 2.47374042 |
| 71 | Respiratory difficulties (HP:0002880) | 2.45709825 |
| 72 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.42951556 |
| 73 | Hyperphosphaturia (HP:0003109) | 2.42117996 |
| 74 | Abnormality of reticulocytes (HP:0004312) | 2.41294697 |
| 75 | Emotional lability (HP:0000712) | 2.35263966 |
| 76 | Proximal tubulopathy (HP:0000114) | 2.31632796 |
| 77 | Metabolic acidosis (HP:0001942) | 2.29787564 |
| 78 | Progressive muscle weakness (HP:0003323) | 2.29546969 |
| 79 | Abnormality of serum amino acid levels (HP:0003112) | 2.29106430 |
| 80 | Microvesicular hepatic steatosis (HP:0001414) | 2.25887273 |
| 81 | Pancytopenia (HP:0001876) | 2.22085055 |
| 82 | Abnormal protein glycosylation (HP:0012346) | 2.20484366 |
| 83 | Abnormal glycosylation (HP:0012345) | 2.20484366 |
| 84 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.20484366 |
| 85 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.20484366 |
| 86 | Gout (HP:0001997) | 2.19501790 |
| 87 | Truncus arteriosus (HP:0001660) | 2.19350706 |
| 88 | Opisthotonus (HP:0002179) | 2.18311520 |
| 89 | Pallor (HP:0000980) | 2.12448309 |
| 90 | Neuroendocrine neoplasm (HP:0100634) | 2.11549370 |
| 91 | Delayed CNS myelination (HP:0002188) | 2.10141785 |
| 92 | Microretrognathia (HP:0000308) | 2.07435115 |
| 93 | Pheochromocytoma (HP:0002666) | 2.06603083 |
| 94 | Reduced antithrombin III activity (HP:0001976) | 2.02804577 |
| 95 | Hypertensive crisis (HP:0100735) | 1.97364841 |
| 96 | Myopathic facies (HP:0002058) | 1.97261103 |
| 97 | Hypobetalipoproteinemia (HP:0003563) | 1.97118648 |
| 98 | Neoplasm of the adrenal gland (HP:0100631) | 1.96431907 |
| 99 | Late onset (HP:0003584) | 1.95718793 |
| 100 | Brushfield spots (HP:0001088) | 1.91657277 |
| 101 | Abnormality of renal resorption (HP:0011038) | 1.90933385 |
| 102 | Progressive microcephaly (HP:0000253) | 1.90922934 |
| 103 | Conjunctival hamartoma (HP:0100780) | 1.89967259 |
| 104 | Spastic paraparesis (HP:0002313) | 1.88570374 |
| 105 | Abnormal urine phosphate concentration (HP:0012599) | 1.87626627 |
| 106 | Breast hypoplasia (HP:0003187) | 1.84499635 |
| 107 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.83183144 |
| 108 | Megaloblastic anemia (HP:0001889) | 1.83088294 |
| 109 | Gliosis (HP:0002171) | 1.82445388 |
| 110 | Aplastic anemia (HP:0001915) | 1.81648931 |
| 111 | Xanthomatosis (HP:0000991) | 1.81644521 |
| 112 | Abnormal trabecular bone morphology (HP:0100671) | 1.81137765 |
| 113 | Death in infancy (HP:0001522) | 1.79012409 |
| 114 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.78237135 |
| 115 | Rough bone trabeculation (HP:0100670) | 1.78232206 |
| 116 | Sparse eyelashes (HP:0000653) | 1.77340122 |
| 117 | Redundant skin (HP:0001582) | 1.76018467 |
| 118 | Seborrheic dermatitis (HP:0001051) | 1.74232115 |
| 119 | Broad distal phalanx of finger (HP:0009836) | 1.73960338 |
| 120 | CNS hypomyelination (HP:0003429) | 1.73072745 |
| 121 | Trismus (HP:0000211) | 1.72199638 |
| 122 | Unsteady gait (HP:0002317) | 1.71899443 |
| 123 | Cerebral hypomyelination (HP:0006808) | 1.71344322 |
| 124 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.71299089 |
| 125 | Hyperlipoproteinemia (HP:0010980) | 1.70796512 |
| 126 | Secondary amenorrhea (HP:0000869) | 1.68639036 |
| 127 | Esophageal neoplasm (HP:0100751) | 1.66956104 |
| 128 | Neoplasm of head and neck (HP:0012288) | 1.66956104 |
| 129 | X-linked dominant inheritance (HP:0001423) | 1.66585168 |
| 130 | Cholelithiasis (HP:0001081) | 1.63063970 |
| 131 | Fasciculations (HP:0002380) | 1.63039595 |
| 132 | Muscle stiffness (HP:0003552) | 1.61321488 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.08258270 |
| 2 | BCKDK | 4.25184902 |
| 3 | STK16 | 3.99812816 |
| 4 | BUB1 | 3.86167257 |
| 5 | WEE1 | 3.35584782 |
| 6 | VRK2 | 3.33834366 |
| 7 | NME1 | 2.76706968 |
| 8 | EIF2AK1 | 2.72184459 |
| 9 | TESK2 | 2.71270802 |
| 10 | ARAF | 2.62476605 |
| 11 | IRAK3 | 2.50881079 |
| 12 | KDR | 2.21968776 |
| 13 | PIM2 | 2.07943612 |
| 14 | DYRK3 | 2.05941243 |
| 15 | MAPKAPK3 | 1.97580350 |
| 16 | NEK1 | 1.97359147 |
| 17 | ACVR1B | 1.82948159 |
| 18 | MAP3K11 | 1.78866890 |
| 19 | BRAF | 1.75660628 |
| 20 | MYLK | 1.68944054 |
| 21 | VRK1 | 1.68497847 |
| 22 | EIF2AK3 | 1.63180505 |
| 23 | TESK1 | 1.55296608 |
| 24 | LIMK1 | 1.46561672 |
| 25 | MST1R | 1.44462767 |
| 26 | WNK3 | 1.35880831 |
| 27 | PLK4 | 1.35209740 |
| 28 | MAP2K2 | 1.34246569 |
| 29 | MAP3K12 | 1.31545660 |
| 30 | SMG1 | 1.27266399 |
| 31 | ABL2 | 1.26756999 |
| 32 | LMTK2 | 1.25004362 |
| 33 | CCNB1 | 1.22915338 |
| 34 | SCYL2 | 1.22634907 |
| 35 | AURKA | 1.20898138 |
| 36 | BRSK2 | 1.19888681 |
| 37 | PDK4 | 1.11106077 |
| 38 | PDK3 | 1.11106077 |
| 39 | DYRK2 | 1.08355111 |
| 40 | TLK1 | 1.07037443 |
| 41 | TTK | 1.00865331 |
| 42 | OBSCN | 1.00845009 |
| 43 | PINK1 | 1.00688977 |
| 44 | ILK | 0.99730338 |
| 45 | RPS6KB2 | 0.99125758 |
| 46 | AURKB | 0.96009861 |
| 47 | PLK1 | 0.95025164 |
| 48 | SRPK1 | 0.94149534 |
| 49 | ERN1 | 0.91953198 |
| 50 | DAPK3 | 0.87563124 |
| 51 | CDC7 | 0.85129518 |
| 52 | WNK4 | 0.82854357 |
| 53 | RPS6KA4 | 0.82780571 |
| 54 | EPHA2 | 0.81033638 |
| 55 | TAOK2 | 0.80715131 |
| 56 | MUSK | 0.76282935 |
| 57 | CDK19 | 0.73330855 |
| 58 | ICK | 0.72099258 |
| 59 | PASK | 0.71903326 |
| 60 | ZAK | 0.71057699 |
| 61 | PBK | 0.70961415 |
| 62 | MAP3K8 | 0.70066262 |
| 63 | FLT3 | 0.69522969 |
| 64 | LRRK2 | 0.68493792 |
| 65 | MAP2K7 | 0.67606025 |
| 66 | PRKCI | 0.67548667 |
| 67 | PAK1 | 0.67491856 |
| 68 | TSSK6 | 0.66602582 |
| 69 | CDK14 | 0.66082811 |
| 70 | PAK4 | 0.65028871 |
| 71 | BRSK1 | 0.63831190 |
| 72 | MAPKAPK5 | 0.63687047 |
| 73 | CSNK2A1 | 0.63506743 |
| 74 | CDK11A | 0.61322210 |
| 75 | CAMK2G | 0.60696597 |
| 76 | CSNK2A2 | 0.59735499 |
| 77 | MAPK15 | 0.59037548 |
| 78 | CDK7 | 0.58537438 |
| 79 | STK4 | 0.58153240 |
| 80 | CSNK1A1L | 0.57146380 |
| 81 | ERBB4 | 0.56543984 |
| 82 | CAMK2D | 0.55858891 |
| 83 | CDK15 | 0.54380784 |
| 84 | KSR2 | 0.53558907 |
| 85 | INSRR | 0.53254950 |
| 86 | GRK6 | 0.53227352 |
| 87 | RPS6KA5 | 0.50851216 |
| 88 | PDK2 | 0.50465791 |
| 89 | CDK18 | 0.50310899 |
| 90 | CHEK1 | 0.50195948 |
| 91 | MAP3K9 | 0.49398730 |
| 92 | STK38L | 0.49206034 |
| 93 | RAF1 | 0.49175936 |
| 94 | MAP3K3 | 0.49037607 |
| 95 | PIK3CA | 0.48327706 |
| 96 | PIK3CG | 0.48254068 |
| 97 | DAPK1 | 0.48226852 |
| 98 | NEK2 | 0.48071239 |
| 99 | MAP2K1 | 0.44881906 |
| 100 | CSNK1G3 | 0.43032734 |
| 101 | CSNK1G2 | 0.42089433 |
| 102 | PHKG2 | 0.41797131 |
| 103 | PHKG1 | 0.41797131 |
| 104 | AKT2 | 0.39411735 |
| 105 | IRAK2 | 0.37304384 |
| 106 | STK24 | 0.37194472 |
| 107 | CAMKK2 | 0.37007460 |
| 108 | MST4 | 0.36983313 |
| 109 | PRKG2 | 0.35938863 |
| 110 | DYRK1B | 0.35870172 |
| 111 | MINK1 | 0.35534918 |
| 112 | CHEK2 | 0.35404648 |
| 113 | TRIB3 | 0.34075693 |
| 114 | CSNK1G1 | 0.31577836 |
| 115 | PLK3 | 0.29424435 |
| 116 | CDK8 | 0.29288720 |
| 117 | CDK4 | 0.28169458 |
| 118 | MAPK11 | 0.27493997 |
| 119 | MET | 0.27231377 |
| 120 | CAMK2B | 0.26357858 |
| 121 | ATR | 0.24099083 |
| 122 | MAP3K5 | 0.22586320 |
| 123 | MOS | 0.22473386 |
| 124 | PAK6 | 0.21864575 |
| 125 | CDK2 | 0.21806244 |
| 126 | CDK1 | 0.21433380 |
| 127 | EEF2K | 0.21337506 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.29185290 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.96476195 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.81923892 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.42068119 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.85119235 |
| 6 | Huntingtons disease_Homo sapiens_hsa05016 | 2.83302773 |
| 7 | Alzheimers disease_Homo sapiens_hsa05010 | 2.67990798 |
| 8 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.58083194 |
| 9 | RNA polymerase_Homo sapiens_hsa03020 | 2.48055332 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.18207043 |
| 11 | DNA replication_Homo sapiens_hsa03030 | 2.10199659 |
| 12 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.00808617 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.00520280 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.98927863 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.96000715 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.90201185 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.85431538 |
| 18 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.76038579 |
| 19 | Sulfur relay system_Homo sapiens_hsa04122 | 1.75306978 |
| 20 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.75204583 |
| 21 | Protein export_Homo sapiens_hsa03060 | 1.74756310 |
| 22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.74603943 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.62596188 |
| 24 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.54435454 |
| 25 | Mismatch repair_Homo sapiens_hsa03430 | 1.52999530 |
| 26 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.42250610 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.40965374 |
| 28 | Spliceosome_Homo sapiens_hsa03040 | 1.39595502 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.36253207 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.35267543 |
| 31 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.33699634 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.25636881 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.25126478 |
| 34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21480796 |
| 35 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.19373987 |
| 36 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.15684518 |
| 37 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.15485777 |
| 38 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.11942797 |
| 39 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.10139581 |
| 40 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.09016774 |
| 41 | Base excision repair_Homo sapiens_hsa03410 | 1.08457443 |
| 42 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.07641995 |
| 43 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.06886030 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.06340861 |
| 45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.05812820 |
| 46 | RNA transport_Homo sapiens_hsa03013 | 1.04538801 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.04380530 |
| 48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.01796505 |
| 49 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.01584239 |
| 50 | Homologous recombination_Homo sapiens_hsa03440 | 1.01010195 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.00451974 |
| 52 | Purine metabolism_Homo sapiens_hsa00230 | 0.99602560 |
| 53 | Metabolic pathways_Homo sapiens_hsa01100 | 0.98738630 |
| 54 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.97485096 |
| 55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.97219315 |
| 56 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.96283992 |
| 57 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.93530792 |
| 58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.91999818 |
| 59 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.89201361 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.88338868 |
| 61 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.86861067 |
| 62 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.85292597 |
| 63 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83315963 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79266219 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.78585798 |
| 66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78318923 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76321520 |
| 68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.74012622 |
| 69 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.72606803 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72271145 |
| 71 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69007104 |
| 72 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68943196 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67326124 |
| 74 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.66237533 |
| 75 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65523923 |
| 76 | Alcoholism_Homo sapiens_hsa05034 | 0.62953906 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60677946 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.54464680 |
| 79 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.52354102 |
| 80 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.51430118 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.50909158 |
| 82 | Basal transcription factors_Homo sapiens_hsa03022 | 0.50108128 |
| 83 | RNA degradation_Homo sapiens_hsa03018 | 0.49065222 |
| 84 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49018831 |
| 85 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.48155528 |
| 86 | Cell cycle_Homo sapiens_hsa04110 | 0.43977768 |
| 87 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.43487307 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43328112 |
| 89 | Retinol metabolism_Homo sapiens_hsa00830 | 0.43134627 |
| 90 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.40284214 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38998252 |
| 92 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.37539733 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37366090 |
| 94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33606468 |
| 95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33031192 |
| 96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.32435493 |
| 97 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.29064179 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28384367 |
| 99 | Bladder cancer_Homo sapiens_hsa05219 | 0.27605296 |
| 100 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.26767339 |
| 101 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.25973446 |
| 102 | Shigellosis_Homo sapiens_hsa05131 | 0.25367280 |
| 103 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.22679723 |
| 104 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.21878882 |
| 105 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.21664574 |
| 106 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.20811910 |
| 107 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.20484500 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.19135448 |
| 109 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.17953491 |
| 110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.17304135 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.16709797 |
| 112 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.16181738 |
| 113 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.16115860 |
| 114 | Other glycan degradation_Homo sapiens_hsa00511 | 0.13819517 |
| 115 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.11614313 |
| 116 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.10399333 |
| 117 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.10146339 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.10102166 |
| 119 | Apoptosis_Homo sapiens_hsa04210 | 0.03486733 |
| 120 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.00713137 |

